当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202011
编号:13485502
组蛋白去乙酰化酶抑制剂小分子抗炎活性的研究(5)
http://www.100md.com 2020年4月15日 《中国医药导报》 202011
     [27] Seet LF,Toh LZ,Finger SN,et al. Valproic acidexerts specific cellular and molecular anti-inflammatory effects in post-operative conjunctiva [J]. J Mol Med(Berl),2019,97(1):63-75.

    [28] 李曉晖,黄美玲,刘丽娜,等.环肽类组蛋白去乙酰化酶抑制剂[J].化学进展,2014,26(9):1527-1536.

    [29] Butler RM,McKenzie RC,Jones CL,et al. Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance [J]. J Invest Derm,2019,139(9):1975-1984.

    [30] 赵晶.组蛋白去乙酰化酶抑制剂FK-228诱导人舌癌细胞的凋亡研究[J].中国现代医生,2018,56(20):44-46.

    [31] 李梦辉.组蛋白去乙酰化酶抑制剂FK228通过NF-κβ通路抑制肝纤维化的实验研究[D].重庆:重庆医科大学,2018.

    [32] Dong M,Ning ZQ,Xing PY,et al. PhaseⅠ study of chidamide(CS055/HBI-8000),a new histone deacetylase inhibitor,in patients with advanced solid tumors and lymphomas [J]. Can Chem,2012,69(6):1413-1422.

    [33] Ryu Y,Kee H,Sun S,et al. ClassⅠ histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin Ⅱ-induced hypertension [J]. PLoS One,2019,14(3):e0213186.

    [34] Leus NG,Bosch T,Wouden P,et al. HDAC1-3 inhibitor MS-275 enhances IL-10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice [J]. Sci Rep,2017,27(7):45047.

    (收稿日期:2019-07-05 本文编辑:王晓晔), 百拇医药(赵诗雨 刘玉甜 匡海学 吕邵娃)
上一页1 2 3 4 5